Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Cryptococcosis in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Baddley JW, Forrest GN; AST Infectious Diseases Community of Practice.

Clin Transplant. 2019 Mar 22:e13543. doi: 10.1111/ctr.13543. [Epub ahead of print]

PMID:
30900315
2.

Improving fluoroquinolone use in the outpatient setting using a patient safety initiative.

Jindai K, Goto M, MacKay K, Forrest GN, Musuuza J, Safdar N, Pfeiffer CD.

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1108-1111. doi: 10.1017/ice.2018.169. Epub 2018 Aug 17.

PMID:
30115219
3.

Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections.

Furuno JP, Tallman GB, Noble BN, Bubalo JS, Forrest GN, Lewis JS 2nd, Bienvenida AF, Holmes CA, Weber BR, McGregor JC.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00893-18. doi: 10.1128/AAC.00893-18. Print 2018 Oct.

4.

Research Agenda for Antimicrobial Stewardship in the Veterans Health Administration.

Suda KJ, Livorsi DJ, Goto M, Forrest GN, Jones MM, Neuhauser MM, Hoff BM, Ince D, Carrel M, Nair R, Knobloch MJ, Goetz MB.

Infect Control Hosp Epidemiol. 2018 Feb;39(2):196-201. doi: 10.1017/ice.2017.299. No abstract available.

PMID:
29417925
5.

Feasibility of monitoring compliance to the My 5 Moments and Entry/Exit hand hygiene methods in US hospitals.

Chang NC, Reisinger HS, Jesson AR, Schweizer ML, Morgan DJ, Forrest GN, Perencevich EN.

Am J Infect Control. 2016 Aug 1;44(8):938-40. doi: 10.1016/j.ajic.2016.02.007. Epub 2016 Apr 6.

6.

Cryptococcus gattii infection in solid organ transplant recipients: description of Oregon outbreak cases.

Forrest GN, Bhalla P, DeBess EE, Winthrop KL, Lockhart SR, Mohammadi J, Cieslak PR.

Transpl Infect Dis. 2015 Jun;17(3):467-76. doi: 10.1111/tid.12370. Epub 2015 May 19.

PMID:
25677448
7.

Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation.

Bhalla P, Forrest GN, Gershon M, Zhou Y, Chen J, LaRussa P, Steinberg S, Gershon AA.

Clin Infect Dis. 2015 Apr 1;60(7):1068-74. doi: 10.1093/cid/ciu970. Epub 2014 Dec 1. Erratum in: Clin Infect Dis. 2015 Jul 1;61(1):143.

8.

Review of rapid diagnostic tests used by antimicrobial stewardship programs.

Bauer KA, Perez KK, Forrest GN, Goff DA.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S134-45. doi: 10.1093/cid/ciu547. Review.

PMID:
25261540
9.

Use of electronic health records and clinical decision support systems for antimicrobial stewardship.

Forrest GN, Van Schooneveld TC, Kullar R, Schulz LT, Duong P, Postelnick M.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S122-33. doi: 10.1093/cid/ciu565.

PMID:
25261539
10.

Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.

Sun HY, Alexander BD, Huprikar S, Forrest GN, Bruno D, Lyon GM, Wray D, Johnson LB, Sifri CD, Razonable RR, Morris MI, Stosor V, Wagener MM, Singh N.

Clin Infect Dis. 2015 Jan 1;60(1):36-44. doi: 10.1093/cid/ciu711. Epub 2014 Sep 9. Erratum in: Clin Infect Dis. 2016 Jun 15;62(12):1621.

11.

Improving hand hygiene compliance with point-of-use reminder signs designed using theoretically grounded messages.

Reisinger HS, Perencevich EN, Morgan DJ, Forrest GN, Shardell M, Schweizer ML, Graham MM, Franciscus CL, Vander Weg MW.

Infect Control Hosp Epidemiol. 2014 May;35(5):593-4. doi: 10.1086/675827. Epub 2014 Mar 14. No abstract available.

PMID:
24709734
12.

Clinical outcomes of a veterans affairs outpatient antimicrobial treatment program.

Mohammadi S, MacKay K, Ward TT, Forrest GN.

South Med J. 2013 Jun;106(6):345-9. doi: 10.1097/SMJ.0b013e3182967e8f.

PMID:
23736174
13.

Cryptococcosis in solid organ transplantation.

Baddley JW, Forrest GN; AST Infectious Diseases Community of Practice.

Am J Transplant. 2013 Mar;13 Suppl 4:242-9. doi: 10.1111/ajt.12116. No abstract available.

14.

The effect of contact precautions on healthcare worker activity in acute care hospitals.

Morgan DJ, Pineles L, Shardell M, Graham MM, Mohammadi S, Forrest GN, Reisinger HS, Schweizer ML, Perencevich EN.

Infect Control Hosp Epidemiol. 2013 Jan;34(1):69-73. doi: 10.1086/668775. Epub 2012 Nov 20.

PMID:
23221195
15.

Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program.

Standiford HC, Chan S, Tripoli M, Weekes E, Forrest GN.

Infect Control Hosp Epidemiol. 2012 Apr;33(4):338-45. doi: 10.1086/664909.

PMID:
22418628
16.

Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study.

Furuno JP, Johnson JK, Schweizer ML, Uche A, Stine OC, Shurland SM, Forrest GN.

BMC Infect Dis. 2011 Oct 31;11:298. doi: 10.1186/1471-2334-11-298.

17.

Single center experience of a vancomycin resistant enterococcal endocarditis cohort.

Forrest GN, Arnold RS, Gammie JS, Gilliam BL.

J Infect. 2011 Dec;63(6):420-8. doi: 10.1016/j.jinf.2011.08.014. Epub 2011 Sep 6.

PMID:
21920382
18.

Management of gram-positive coccal bacteremia and hemodialysis.

Fitzgibbons LN, Puls DL, Mackay K, Forrest GN.

Am J Kidney Dis. 2011 Apr;57(4):624-40. doi: 10.1053/j.ajkd.2010.12.013. Epub 2011 Feb 18.

PMID:
21333430
19.

Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States.

Osawa R, Alexander BD, Forrest GN, Lyon GM, Somani J, del Busto R, Pruett TL, Sifri CD, Limaye AP, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Kalil AC, Garcia-Diaz J, Orloff SL, Houston SH, Wray D, Huprikar S, Johnson LB, Razonable RR, Fisher RA, Wagener MM, Husain S, Singh N.

Ann Transplant. 2010 Oct-Dec;15(4):77-83.

PMID:
21183881
20.

Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients.

Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N; Cryptococcal Collaborative Transplant Study Group.

Clin Infect Dis. 2010 Nov 1;51(9):1062-9. doi: 10.1086/656584.

PMID:
20879857
21.

Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences.

Espinosa-Aguilar L, Green JS, Forrest GN, Ball ED, Maziarz RT, Strasfeld L, Taplitz RA.

Biol Blood Marrow Transplant. 2011 Apr;17(4):566-73. doi: 10.1016/j.bbmt.2010.07.018. Epub 2010 Aug 11.

22.

Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs.

Crompton JA, North DS, Yoon M, Steenbergen JN, Lamp KC, Forrest GN.

J Antimicrob Chemother. 2010 Aug;65(8):1784-91. doi: 10.1093/jac/dkq200. Epub 2010 Jun 16.

23.

Statins in candidemia: clinical outcomes from a matched cohort study.

Forrest GN, Kopack AM, Perencevich EN.

BMC Infect Dis. 2010 Jun 4;10:152. doi: 10.1186/1471-2334-10-152.

24.

Cutaneous cryptococcosis in solid organ transplant recipients.

Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Muñoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N; Cryptococcal Collaborative Transplant Study Group.

Med Mycol. 2010 Sep;48(6):785-91. doi: 10.3109/13693780903496617.

PMID:
20100136
25.

Rifampin combination therapy for nonmycobacterial infections.

Forrest GN, Tamura K.

Clin Microbiol Rev. 2010 Jan;23(1):14-34. doi: 10.1128/CMR.00034-09. Review.

26.

Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis.

Osawa R, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Muñoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N.

Transplantation. 2010 Jan 15;89(1):69-74. doi: 10.1097/TP.0b013e3181bcda41.

27.

Lack of fluoroquinolone resistance in non-typhoidal salmonella bacteremia in HIV-infected patients in an urban US setting.

Forrest GN, Wagner LA, Talwani R, Gilliam BL.

J Int Assoc Physicians AIDS Care (Chic). 2009 Nov-Dec;8(6):338-41. doi: 10.1177/1545109709352883.

PMID:
19952286
28.

Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis.

Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Husain S, Singh N.

Clin Infect Dis. 2009 Dec 1;49(11):1721-8. doi: 10.1086/647948.

29.

Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair.

Shang E, Forrest GN, Chizmar T, Chim J, Brown JM, Zhan M, Zoarski GH, Griffith BP, Gammie JS.

Ann Thorac Surg. 2009 Jun;87(6):1728-33; discussion 1734. doi: 10.1016/j.athoracsur.2009.02.098.

PMID:
19463586
30.

Risk factors for mortality from primary cryptococcosis in patients with HIV.

Sajadi MM, Roddy KM, Chan-Tack KM, Forrest GN.

Postgrad Med. 2009 Mar;121(2):107-13. doi: 10.3810/pgm.2009.03.1983.

PMID:
19332968
31.

Community-acquired methicillin-resistant Staphylococcus aureus endomyocardial abscesses in a heart transplant recipient.

Oyler A, Riveros-Angel M, Shaw K, Forrest GN.

Transpl Infect Dis. 2009 Feb;11(1):64-7. doi: 10.1111/j.1399-3062.2008.00343.x. Epub 2008 Sep 21.

PMID:
18811630
32.

Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.

Forrest GN, Roghmann MC, Toombs LS, Johnson JK, Weekes E, Lincalis DP, Venezia RA.

Antimicrob Agents Chemother. 2008 Oct;52(10):3558-63. doi: 10.1128/AAC.00283-08. Epub 2008 Jul 28.

33.

Approaches to management of invasive fungal infections in patients with hematologic malignancies.

Forrest GN, Walsh TJ.

Support Cancer Ther. 2004 Oct 1;2(1):21-30. doi: 10.3816/SCT.2004.n.019.

PMID:
18628154
34.

Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus.

Riedel DJ, Weekes E, Forrest GN.

Antimicrob Agents Chemother. 2008 Jul;52(7):2463-7. doi: 10.1128/AAC.00300-08. Epub 2008 May 12.

35.

Clinical experience with daptomycin for the treatment of patients with documented gram-positive septic arthritis.

Forrest GN, Donovan BJ, Lamp KC, Friedrich LV.

Ann Pharmacother. 2008 Feb;42(2):213-7. doi: 10.1345/aph.1K535. Epub 2008 Jan 22.

PMID:
18212253
36.

Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.

Forrest GN, Weekes E, Johnson JK.

J Infect. 2008 Feb;56(2):126-9. Epub 2007 Dec 21.

PMID:
18082269
37.

Potential clinical benefit of donor lymphocyte infusion in the treatment of refractory invasive fungal pneumonia.

Ilyas C, Forrest GN, Akpek G.

Bone Marrow Transplant. 2007 Sep;40(6):599-601. Epub 2007 Jul 9. No abstract available.

PMID:
17618316
38.

Rhodotorula glutinis fungemia in a liver-kidney transplant patient.

Riedel DJ, Johnson JK, Forrest GN.

Transpl Infect Dis. 2008 Jun;10(3):197-200. Epub 2007 Jul 1.

PMID:
17605726
39.

PNA FISH: present and future impact on patient management.

Forrest GN.

Expert Rev Mol Diagn. 2007 May;7(3):231-6. Review.

PMID:
17489730
40.

Outcomes of invasive zygomycosis infections in renal transplant recipients.

Forrest GN, Mankes K.

Transpl Infect Dis. 2007 Jun;9(2):161-4.

PMID:
17462005
41.

Polymyxin antibiotics for gram-negative infections.

Arnold TM, Forrest GN, Messmer KJ.

Am J Health Syst Pharm. 2007 Apr 15;64(8):819-26. Review.

PMID:
17420197
42.

Safety and efficacy of micafungin in transplantation recipients.

Forrest GN, Rasetto F, Akpek G, Philosophe B.

Transplantation. 2006 Dec 15;82(11):1549. No abstract available.

PMID:
17164733
43.

Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs.

Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lincalis DP, Venezia RA.

J Clin Microbiol. 2006 Sep;44(9):3381-3.

44.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S. aureus Endocarditis and Bacteremia Study Group.

N Engl J Med. 2006 Aug 17;355(7):653-65.

45.

Febrile neutropenia associated with painful lesions of the palms and digits.

Henn SL, Forrest GN.

Clin Infect Dis. 2006 Sep 15;43(6):747, 791-2. No abstract available.

PMID:
16912950
46.

Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures.

Forrest GN, Mehta S, Weekes E, Lincalis DP, Johnson JK, Venezia RA.

J Antimicrob Chemother. 2006 Jul;58(1):154-8. Epub 2006 Apr 24.

PMID:
16636084
47.

Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial.

McGregor JC, Weekes E, Forrest GN, Standiford HC, Perencevich EN, Furuno JP, Harris AD.

J Am Med Inform Assoc. 2006 Jul-Aug;13(4):378-84. Epub 2006 Apr 18.

48.

The use of vaccines in adult patients with renal disease.

Dinits-Pensy M, Forrest GN, Cross AS, Hise MK.

Am J Kidney Dis. 2005 Dec;46(6):997-1011. Review.

PMID:
16310566
49.

A 76-year-old man with fever and weakness.

Forrest GN, Mackowiak PA, Schlossberg MC, Meyer CF.

Am J Med Sci. 2005 Jul;330(1):32-5. No abstract available.

PMID:
16020997
50.

Febrile neutropenia, colony-stimulating factors and therapy: time for a new methodology?

Forrest GN, Schimpff SC, Cross A.

Support Care Cancer. 2002 Apr;10(3):177-80. Epub 2002 Feb 20.

PMID:
11904781

Supplemental Content

Loading ...
Support Center